Citations

Clear

1792 citation(s) found for "Stephanie".

Predictors of learning the memory support system in individuals with amnestic mild cognitive impairment
Koay, Jun Min , Grant, Jeremy G , Aghamoosa, Stephanie , Shandera-Ochsner, Anne L, Chandler, Melanie J

Mayo Clinic

Journal of Clinical and Experimental Neuropsychology | November 12, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-9

10.1080/13803395.2026.2762996 | PMID 43018120 Get It

Validation of the Perimenopause Symptom Scale (Peri-SS) for digital self-assessment: psychometric evaluation among US women aged 35 to 59 years
Xu, Yihan , Faubion, Stephanie

Mayo Clinic

Menopause | November 11, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/gme.0000000000002948 | PMID 43012501 Get It

Objective: Perimenopause is an under-recognized transition poorly measured by existing tools, which often overlook symptoms characteristic of this phase. To address this, we developed and validated the Perimenopause Symptom Scale (Peri-SS): a concise, phase-specific, psychometrically robust instrument for digital self-assessment and research use among US women aged 35-59 who self-reported being in perimenopause. Methods: We conducted a longitudinal validation study with 1,255 US women aged 35-59 (633 self-identified as perimenopausal) recruited via Prolific. Participants completed the Peri-SS, Menopause Rating Scale (MRS), and EuroQol 5-Dimension, 5-Level (EQ-5D-5L) questionnaire at baseline and 7-14 days later. Following COSMIN guidelines, we assessed structural validity, internal consistency, test-retest reliability, criterion and construct validity, and responsiveness to change. Results: The Peri-SS demonstrated strong psychometric performance. Confirmatory factor analysis confirmed a four-domain structure (vasomotor, psychological, sexual, physical), with excellent model fit (CFI=0.932, RMSEA=0.069). Internal consistency was excellent (α=0.90 overall; domain range 0.73-0.86), and test-retest reliability was high (ICC=0.82). Criterion validity was strong, with Peri-SS scores highly correlated with Menopause Rating Scale ( r =0.88). Construct validity was supported through moderate correlations with EQ-5D-5L utilities (ρ=−0.50) and effective discrimination between groups by age, reproductive stage, and hormone therapy use. The scale was also responsive to symptom changes over time (η²=0.277). Conclusions: The Peri-SS is a reliable, valid, responsive tool for assessing perimenopausal symptom burden. Its concise format and strong psychometric performance make it well-suited for research, clinical care, and digital health applications.
Severe and very severe ME/CFS – when healthcare is out of reach: A qualitative study
Hackl, Verena , Hainzl, Astrid, Wojczewski, Silvia , Maukner, Anna, Mair, Lucia, Saugstad, Ola Didrik , Grach, Stephanie L. , Hoffmann, Kathryn

Mayo Clinic

No container title available | November 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-11494085/v1 Get It

Abstract Severe and very severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) causes profound functional impairment and substantial multisystem manifestations, leaving many home- or bed-bound, highly dependent on family/lay caregivers, and often invisible to healthcare. This qualitative study explored healthcare experiences, unmet needs, and barriers to healthcare access among people with severe and very severe ME/CFS, their family/lay caregivers, and healthcare professionals in Austria. Adapted narrative and semi-structured interviews were conducted alongside focus groups and expert interviews with healthcare professionals. Data were analysed using qualitative thematic analysis. Our findings suggest that knowledge gaps, absent or limited transportability, and insufficiently adapted healthcare services restricted access to necessary care, and could even make healthcare itself a risk for deterioration. Family/Lay caregivers frequently assumed coordinative, nursing, and medical responsibilities in the absence of accessible professional support. Improving provision for this population requires models designed around the functional capacities and individual needs of people with severe and very severe ME/CFS, including home-based and outreach care, telemedicine, multidisciplinary coordination, adapted routine and emergency care, and ME/CFS-specific professional education. Future studies should evaluate such models and strengthen research inclusion, particularly of people with very severe ME/CFS.
Agentic AI-Generated vs. Clinician-Authored Hospital Course Narratives for Cardiology Hospitalizations: A Blinded Physician Evaluation
Lee, Eunjung , Harmon, David , Holmes, Jason , Allman, Alexandra E. , Saey, Stephanie , Schlesinger, Reid P , Félix, Iuri Ferreira , Friedman, Paul A , Attia, Zachi I.

Mayo Clinic

Circulation: Population Health and Outcomes | November 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1161/circoutcomes.126.014472 | PMID 42993583 Get It

Background: Discharge summaries are essential for safe transitions of care, but writing the hospital course narrative is time intensive. Large language models can generate plausible clinical narratives, yet prior approaches often rely on static inputs and remain vulnerable to omissions and factual inconsistencies. Methods: We developed an electronic health record (EHR)-integrated agentic artificial intelligence (AI) system that uses Gemini 2.5 Pro and Model Context Protocol tools to retrieve clinical notes, diagnostic reports, diagnoses, medications, and appointments on demand. In this retrospective, blinded, paired study, 50 inpatient cardiology encounters were randomly selected from admissions July 13 to 27, 2024, at Mayo Clinic, Rochester, Minnesota. Five physicians rated AI-generated and clinician-authored hospital course narratives for each encounter (250 ratings) on 0-to-10 scales for overall quality, clarity, completeness, accuracy, and readability and indicated a preference. The primary outcome was the paired difference in overall quality (linear mixed-effects model with crossed random intercepts for encounter and reviewer). Secondary domains were analyzed similarly with Bonferroni adjustment, and preference with a crossed random-effects logistic model. Results: Clinician-authored narratives were preferred in 132 ratings (52.8%) and AI-generated narratives in 118 (47.2%) (odds ratio for clinician-authored preference, 1.12; 95% CI, 0.71 to 1.78). Overall quality did not differ significantly (mean, 7.27 AI-generated versus 7.42 clinician-authored; difference, -0.15; 95% CI, -0.86 to 0.56; p=0.627). AI-generated narratives were rated higher for clarity (0.36; 95% CI, 0.07 to 0.65) and readability (0.72; 95% CI, 0.20 to 1.24) but lower for completeness (-0.84; 95% CI, -1.36 to -0.32) and accuracy (-0.35; 95% CI, -0.66 to -0.05). After Bonferroni correction, only lower completeness remained significant (adjusted p=0.012). Conclusions: Hospital course narratives generated by the EHR-integrated agentic AI system did not differ significantly from clinician-authored narratives in physician-rated overall quality or preference. Lower completeness supports continued clinician review before use in the medical record.
A Three-Day Postoperative Recovery Pathway After Robotic Pancreatoduodenectomy
Yu, Stephanie, Cheung, Dillon, Stucky, Chee-Chee, Tan, Po Hong, Sanford, Dominic E. , Bold, Rick J., Wasif, Nabil , Fong, Zhi Ven

Mayo Clinic

Annals of Surgery Open | November 4, 2026 | Volume: 7 | Issue: 4 | Pages: e722

10.1097/as9.0000000000000722 Get It

Background and Objective: Enhanced Recovery After Surgery (ERAS) protocols and minimally invasive techniques may accelerate recovery following pancreatoduodenectomy (PD). We evaluated the feasibility and safety of combining minimally invasive PD with a tailored ERAS protocol on post-PD outcomes and quality of life (QoL). Methods: Patients undergoing PD from 2023 to 2025 were identified. The 2019 ERAS Society recommendations for PD were implemented. Multivariable regression was used for adjusted analyses, with performance assessed by area under the curve (AUC) and Brier scores. QoL was measured using the European Organisation for Research and Treatment of Cancer QLQ-C30 and PAN-26 modules. Results: Of 113 patients, 67.3% underwent robotic and 32.7% open PD with comparable baseline characteristics. Postoperative day (POD) 3 discharge occurred in 34.2% of robotic cases and none of the open cases ( P < 0.001). POD 3 discharge correlated with fewer cumulative 90-day hospital days (3 days vs 5 days, P < 0.001) and overall complications (42.3% vs 68.0%, P = 0.031), without differences in major complications, readmissions, or 90-day mortality. POD 1 drain fluid amylase (DFA) was lower in POD 3 discharges (40 U/L vs 808 U/L, P = 0.014), and DFA <300 U/L identified patients likely to achieve POD 3 discharge without adverse events with good discrimination and calibration (AUC = 0.843; Brier = 0.120). Early discharge was associated with improved overall QoL (+5.6 vs −15.0; P = 0.006) without differences in pain scores (+8.3 vs +12.5; P = 0.240). Conclusions: ERAS protocols with minimally invasive PD facilitated safe POD 3 discharge. POD 1 DFA <300 U/L may help identify patients safe for early discharge without compromising outcomes or QoL.
Disagreement Between Outpatient Complications in the USNWR ENT Ratings and Clinical Adjudication
Pollock, Benjamin D , Anderson, Stephanie S., Vaver, Anne M, Devkaran, Subashnie, Tasche, Kendall K.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | October 13, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/ohn.70494 | PMID 42867264 Get It

Abstract Objective In 2024, the US News and World Report (USNWR)'s Best Hospitals began reporting complications following elective outpatient otolaryngology procedures in its ears, nose, and throat (ENT) ranking. However, this methodology has not been clinically adjudicated in a peer‐reviewed domain. We aimed to conduct manual health record adjudication to assess whether the USNWR methodology accurately attributes complications following elective outpatient otolaryngology procedures. Study Design Case‐cohort. Setting A case‐cohort of n = 80 elective, outpatient otolaryngology procedure/complication pairings from January 2019 to October 2023 across four academic medical centers using the 2024 USNWR otolaryngology procedure subgroups and Solventum Ambulatory Potentially Preventable Complications (AM‐PPC) software. Methods We used the AM‐PPC‐defined complication types as our standard of comparison for our clinical adjudication. Using the electronic health record, we adjudicated: (1) Was there agreement (yes/no) on complication type between our clinical adjudication and the Solventum AM‐PPC software? (2) Was the complication clinically related to, or a sequela of, the index otolaryngology procedure (yes/no)? Results The clinical adjudication agreed on complication type in 59/80 (74%) of patients, and 63/80 (79%) were judged to be clinically related to the index otolaryngology procedure. In total, 50/80 (63%) complications were adjudicated to be in agreement on both the complication type and clinical relatedness to the index procedure, while 9/80 (11%) complications did not agree with the complication type nor were clinically related to the index procedure. Conclusion Outpatient complications reported in the USNWR ENT rating lack the specificity to exclude patients whose complications are sequelae of chronic underlying conditions or related to concurrent, non‐otolaryngology procedures.
“Railroad Track” Brain Fluorodeoxyglucose-PET Sign in Antiphospholipid Syndrome–Related Posterior Cortical Atrophy
Segal, Yahel , Aksamit, Allen J. , McCarter, Stuart J , Syc-Mazurek, Stephanie B , Chen, John J , Cascino, Gregory D , Banks, Samantha

Mayo Clinic

Neurology | October 7, 2026 | Volume: 107 | Issue: 9 | Pages: No page available

10.1212/wnl.0000000000218621 | PMID 42842850 Get It

The New ACP Clinical Guideline for the Pharmacologic Treatment of Menopausal Vasomotor Symptoms: Where Do We Go From Here?
Castaneda, Regina , Faubion, Stephanie S

Mayo Clinic

Annals of Internal Medicine | October 5, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7326/annals-26-03184 | PMID 42832806 Get It

Functional Hypothalamic Amenorrhea Phenotype and Cardiovascular Disease Risk
Stuart, Jennifer , Karam, Jana , Che, Xiaoyu , Manson, JoAnn E. , Miller, Karen K. , Rexrode, Kathy, Faubion, Stephanie S. , Berga, Sarah L. , Merz, C. Noel Bairey , Rich‐Edwards, Janet W.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | October 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1210/clinem/dgag405 | PMID 42831273 Get It

Abstract Context Menstrual irregularities have been associated with cardiovascular disease (CVD) risk, but underlying etiologies may confer distinct risk profiles. Functional hypothalamic amenorrhea (FHA) has not been evaluated as a separate risk phenotype. Objective To assess the association between FHA phenotype and incident CVD and cardiometabolic risk factors. Design Prospective cohort study with biennial follow-up from 1993 to 2019. Setting Nurses’ Health Study II cohort. Participants The sample included 52,655 premenopausal women free of CVD in 1993. FHA phenotype was defined as irregular or absent cycles without PCOS traits combined with low body mass index and/or high physical activity. Intervention None Main Outcome Measures Incident CVD (coronary heart disease [CHD; myocardial infarction or coronary revascularization] and stroke) and incident elevated cholesterol, hypertension, and type 2 diabetes (T2DM). Results During up to 26 years of follow-up, 1,007 CVD events occurred. Among women who developed CVD, the median time to the first CVD event was 17.0 years (IQR, 11.3-21.0). FHA phenotype in mid-adulthood was associated with a 62% higher risk of CVD (95% confidence interval [CI]: 1.01–2.59), driven by an almost two-fold higher risk of CHD (hazard ratio [HR] = 1.91; 95% CI: 1.11–3.27), compared with women with regular cycles. FHA was also associated with T2DM (HR = 1.86; 95% CI: 1.41–2.47), but not hypertension or elevated cholesterol. Non-FHA menstrual irregularity was associated with elevated cholesterol, hypertension, and T2DM, but not CVD. FHA in early adulthood was not associated with outcomes. Conclusions FHA phenotype in mid-adulthood was associated with increased CHD risk independent of traditional risk factors. Menstrual history may serve as an early marker of cardiometabolic risk.
Geographic Variation in Diagnostic Codes Associated With Mild Cognitive Impairment, Alzheimer Disease, and Related Dementias
Zafar, Sahar F. , Moura, Lidia M.V.R. , Gorham, Brittany , Ndemo, Esther , Swanson, Stephanie , Day, Gregory S. , Schelke, Matthew W. , Kummer, Benjamin R. , Garg, Neeta , Wilson, Andrew , Jones, Lyell K.

Mayo Clinic

Neurology Clinical Practice | September 28, 2026 | Volume: 16 | Issue: 6 | Pages: No page available

10.1212/cpj.0000000000200658 | PMID 42804729 Get It